Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials

Fig. 3

Association between the risk of major adverse cardiovascular events (MACE) and A HbA1c reduction or B bodyweight change. The thicker line shows meta-regression with 95% CI as shading. The circle size of each trial reflects the study weight. HbA1c glycated hemoglobin, CI confidence interval, Ln(RR) estimated log risk ratio

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840